Patents by Inventor Pascal Arnoux

Pascal Arnoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190085338
    Abstract: The invention concerns magnetotactic bacteria modified to express metallophores and their use in bioremediation, biodetection, imaging, as well as the use of magnetosomes extracted from such bacteria in several indications including antitumor treatment and in a process of metal recovery.
    Type: Application
    Filed: November 7, 2016
    Publication date: March 21, 2019
    Applicant: Commissariat a l'Energie Atomique et aux Energies Alternatives
    Inventors: David Pignol, Monique Sabaty, Pascal Arnoux, Jean-Baptiste Abbe
  • Patent number: 8563280
    Abstract: The invention relates to a nicotianamine derivative and to a process for chemical or enzymatic synthesis thereof. The nicotianamine derivative has the following formula (I). The invention finds use in the pharmacy field in particular.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: October 22, 2013
    Assignees: Commissariat a l'Energie Atomique et aux Energies Alternatives, Centre National de la Recherche Scientifique
    Inventors: Cyril Dreyfus, David Pignol, Pascal Arnoux, Florine Cavelier, Manuel Larrouy, Jean Martinez
  • Publication number: 20120095262
    Abstract: The invention relates to a nicotianamine derivative and to a process for chemical or enzymatic synthesis thereof. The nicotianamine derivative has the following formula (I). The invention finds use in the pharmacy field in particular.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 19, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Cyril Dreyfus, David Pignol, Pascal Arnoux, Florine Cavelier, Manuel Larrouy, Jean Martinez